A Caregiver-Assisted Rehabilitation With Strategy Training (CAR-ST) for Stroke Patients

Launched by TAIPEI MEDICAL UNIVERSITY · Dec 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help stroke survivors improve their daily activities by involving their caregivers. The program, called Caregiver-Assisted Rehabilitation with Strategy Training (CAR-ST), aims to see if having a caregiver participate in the training can lead to better recovery outcomes compared to just training the stroke survivor alone or providing educational support. The researchers want to find out if the CAR-ST method can help stroke survivors perform daily activities better and if these improvements extend to other areas of their recovery.

To be eligible for the trial, participants should be adults aged 65 to 74 who have had a stroke and are willing to provide consent. They should also have a caregiver who can assist them. Participants will take part in either the CAR-ST program, strategy training alone, or an education program, with sessions held once or twice a week until they complete ten sessions. Throughout the study, their progress will be checked at four different times: before starting the program, right after finishing it, and again at three and six months later. This is an exciting opportunity for stroke survivors to potentially gain significant help in their recovery journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being willing to provide informed consent
• • Diagnosis with ischemic and/or hemorrhagic stroke
• • Modified Rankin Scale (mRS) ranges from 2 to 4
• • Rehabilitation frequency less than 3 days per week
• • Having a healthy caregiver
• Exclusion Criteria:
• • Undergoing palliative care
• • Major diseases or severe conditions influencing study participation, such as global aphasia, dementia, multiple organ failure, immobilization due to fracture, etc
• • Moderate post-stroke cognitive impairment, with Montreal Cognitive Assessment score \<22
• • Pre-stroke mRS \> 1
• • Participating in other interventional study concurrently.